Abstract: A play apparatus has a pair of devices. Each device has: a capture arrangement such as a cavity to capture an object such as a ball; an object detector to detect that the object has been captured; a transmission module to transmit a release signal; a receiver module to receive a release signal; and a release actuator to release the captured object. A first device detects capture of a first object, transmits a first release signal to cause a second device to release a second object. The first device withholds the first object until releasing it responsive to receipt of a second release signal indicating that another object has been captured by the second device.

Abstract: A play apparatus has a pair of devices. Each device has: a capture arrangement such as a cavity to capture an object such as a ball; an object detector to detect that the object has been captured; a transmission module to transmit a release signal; a receiver module to receive a release signal; and a release actuator to release the captured object. A first device detects capture of a first object, transmits a first release signal to cause a second device to release a second object. The first device withholds the first object until releasing it responsive to receipt of a second release signal indicating that another object has been captured by the second device.

Abstract: The invention relates to methods for treating tissue injury and/or afflictions, by administering a prophylactically or therapeutically effective amount of particulate, bioavailable ?(1-3;1-6) glucan. The invention also relates to methods in which ?(1-3;1-6) glucan is provided in the form of whole glucan particles, microparticulate ?-glucan particles or a combination thereof. The invention also relates to method of enhancing glucan-mediated committed stem cell proliferation and expansion after injury via the complement system.

Abstract: The present invention relates to methods of using whole glucan particles and complement activating antibodies for antitumor therapy. Whole glucan particles enhance the tumoricidal activity of the innate immune system by binding to the C3 complement protein receptor CR3. This binding enhances innate immune system cytotoxicity, as well as stimulating the release of activating cytokines.

Abstract: The present invention relates to methods of using neutral soluble glucan and monoclonal antibodies for antitumor therapy. Neutral soluble Beta (1,3; 1,6) glucan (NSG) enhances the tumoricidal activity of the innate immune system by binding to the C3 complement protein receptor CR3. The glucan does not stimulate the induction of inflammatory cytokines. Also described are methods of using whole glucan particles (WGP) as an immunomodulator by inducing a shift from a Th2 response to the Th1 response, leading to an enhanced antitumor cytotoxic T-cell response.

Abstract: The invention relates to methods for treating and preventing radiation and/or chemotherapy related injury and/or afflictions, such as myelosuppression and decreased macrophage activity, by administering a prophylactically or therapeutically effective amount of particulate, bioavailable ?(1,3; 1,6) glucan. The invention also relates to methods in which ?(1,3; 1,6) glucan is provided in the form of whole glucan particles, microparticulate ?-glucan particles or a combination thereof.

Abstract: An apparatus and method for removing antlers from animals in a manner that is substantially painless, and thus humane, and that utilizes a particular banding tool and novel band.

Abstract: A chip for performing an electrophoretic separation of micromolecular or macromolecular structures in two dimensions comprises a base substrate comprising a main surface. A channel is formed in the main surface of said base substrate in a first direction, wherein a first voltage is applicable across the channel in order to allow a separation of micromolecular structures or macromolecular structures in the first direction on the basis of a first separation mechanism. In addition, a two-dimensional separation matrix is formed in the main surface of the base substrate, wherein the separation matrix comprises a shallow recess and an array of stand-alone posts arranged in the recess. The recess extends perpendicular from the channel in a second direction, wherein a second voltage is applicable across the separation matrix in order to allow a separation of the structures on the basis of a second separation mechanism.

Abstract: A sail envelope has an internal mast or spar and one or more profiles (1) that is or are free to rotate relative to the longitudinal axis of the mast. Each profile has an outer edge in the form of a symmetrical aerofoil upon which the inner sides of the external sail surfaces bear.